Data & Intelligence
Private Equity and Health Care in Emerging Markets
Posted On: 19 Dec 2016 | In many ways, health care exemplifies EMPEA’s belief that emerging markets (EM) private equity provides investors the opportunity for outsized returns, as well as positive social impact. Demand for health care products and services has grown faster than overall EM economic activity, and the needs of consumers have outstripped the capacity of public sector options. Many governments, faced with budgetary pressures and preoccupied with ensuring macroeconomic stability in a volatile global landscape, have recognized the need for increased private investment in the sector. It’s therefore no surprise that health care private equity investment activity in emerging markets has reached the highest levels ever recorded by EMPEA. Yet delivering on the promise of health care in emerging markets requires not just an opportunistic mindset, but patience, creativity and operational insight into what is ultimately a very complex sector.
Rashad Kaldany | Executive Vice-President and Growth Markets, CDPQ
David Rubenstein | Co-Founder and Managing Director, The Carlyle Group